From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults ; volume:9 ; number:1 ; day:23 ; month:12 ; year:2016 ; pages:1-6 ; date:12.2016
BMC Research Notes / Biomed Central; 9, Heft 1 (23.12.2016), 1-6, 12.2016
- Keyword
-
Allergie
Immunkrankheit
- Contributor
-
Namakoola, Ivan
Kasamba, Ivan
Mayanja, Billy N.
Kazooba, Patrick
Lutaakome, Joseph
Lyagoba, Fred
Kapaata, Anne A.
Kaleebu, Pontiano
Munderi, Paula
SpringerLink (Online service)
- DOI
-
10.1186/s13104-016-2309-7
- URN
-
urn:nbn:de:1111-201701223056
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Namakoola, Ivan
- Kasamba, Ivan
- Mayanja, Billy N.
- Kazooba, Patrick
- Lutaakome, Joseph
- Lyagoba, Fred
- Kapaata, Anne A.
- Kaleebu, Pontiano
- Munderi, Paula
- SpringerLink (Online service)
Other Objects (12)
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
Patients’ Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIV
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models
Treatment effects of the differential first-line antiretroviral regimens among HIV/HBV coinfected patients in southwest China: an observational study
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
CD56 expression predicts response to Daratumumab-based regimens
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam
HIV drug resistance in children with treatment failure to first-line regimens in Ho Chi Minh City, Vietnam
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma
Response to second line antiretroviral therapy in India
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
Patients’ Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIV
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models
Treatment effects of the differential first-line antiretroviral regimens among HIV/HBV coinfected patients in southwest China: an observational study
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
CD56 expression predicts response to Daratumumab-based regimens
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam
HIV drug resistance in children with treatment failure to first-line regimens in Ho Chi Minh City, Vietnam
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma
Response to second line antiretroviral therapy in India
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
Patients’ Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIV
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models
Treatment effects of the differential first-line antiretroviral regimens among HIV/HBV coinfected patients in southwest China: an observational study
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
CD56 expression predicts response to Daratumumab-based regimens
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam
HIV drug resistance in children with treatment failure to first-line regimens in Ho Chi Minh City, Vietnam
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma